Codiak Biosciences Inc (CDAK) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Codiak Biosciences Inc   (NASDAQ: CDAK)


Codiak Biosciences Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Codiak Biosciences Inc's ROI in the third quarter of 2022?
Codiak Biosciences Inc recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -17.92%.

Within the Healthcare sector 329 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2022 quarter, so far to 3875, from total ROI ranking in the second quarter of 2022 at 4057.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM -14.97 % -6.91 % 5.6 % 73.32 % 163.01 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 87 87 104 110 101
Return On Investment (TTM) -17.92 % -19.73 % -32.14 % -31.65 % -62.8 %
CDAK's Overall Ranking # 3875 # 4057 # 4389 # 4596 # 4291
Seq. Investment Change TTM -3.38 % -7.31 % -7.59 % 2.73 % 5.78 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -17 -20 -35 -37 -72

CDAK Company Profile >> Back to CDAK Roi Comparisons >> See Annual CDAK Return On Investment



Return On Investment CDAK's Ranking
Within: No.
Industry # 32
Sector # 330
Overall # 3875

Return On Investment Statistics
High Average Low
-13.31 %
-47.75 %
-185.85 %
(Sep 30 2022)   (Sep 30 2020)







Financial Statements
Codiak Biosciences Inc's III. Quarter Investments $ 87 Millions CDAK's Balance sheet
Codiak Biosciences Inc's III. Quarter Income $ -19 Millions Quarterly CDAK's Income Statement
CDAK's Income by Division See CDAK's Income by Division


CDAK Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions 110 97 0 0 0
Y / Y Investment Growth 12.84 % - - - -
Net Income in Millions -37 -92 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -33.9 % -94.35 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDAK's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDAK's Competitors
Subscribers only: Roi for Codiak Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CDAK's Customers

Other Ratios
CDAK's Roa CDAK's Inventory Turnover Ratio CDAK's Growth Rates CDAK's Dividend Statistics
CDAK's Profitability Ratios CDAK's Asset Turnover Ratio CDAK's Dividend Growth
CDAK's Roe CDAK's Valuation Ratios CDAK's Financial Strength Ratios CDAK's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.